Understanding the roles of gingival beta-defensins

Journal of Oral Microbiology

Volumn 4, Issue 2012, 2012, Pages

  Gursoy, Ulvi Kahraman ^a   Könönen, Eija ^a  

^a UNIVERSITY OF TURKU   (Finland)

Author keywords

Bacteria; Beta defensins; Epithelium; Periodontium

Indexed keywords

BETA DEFENSIN; BETA DEFENSIN 1; BETA DEFENSIN 2; BETA DEFENSIN 3; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 22; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIINFLAMMATORY ACTIVITY; BACTERIAL COLONIZATION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DNA POLYMORPHISM; DRUG EFFICACY; DRUG MECHANISM; FUSOBACTERIUM NUCLEATUM; GINGIVITIS; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; NONHUMAN; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN SECRETION; REVIEW; TREPONEMA DENTICOLA; WOUND HEALING;

EID: 84864797071     PISSN: None     EISSN: 20002297     Source Type: Journal    
DOI: 10.3402/jom.v4i0.15127     Document Type: Review

References (70)

1. Dale BA, Kimball JR, Krisanaprakornkit S, Roberts F, Robinovitch M, O'Neal R, et al. Localized antimicrobial peptide expression in human gingiva. J Periodontal Res 2001; 36: 285-94.
2. Diamond G, Zasloff M, Eck H, Brasseur M, Maloy WL, Bevins CL. Tracheal antimicrobial peptide, a cysteine-rich peptide from mammalian tracheal mucosa: peptide isolation and cloning of a cDNA. Proc Natl Acad Sci USA 1991; 88: 3952-6.
3. Bensch KW, Raida M, Mägert HJ, Schulz-Knappe P, Forssmann WG. hBD-1: a novel beta-defensin from human plasma. FEBS Lett 1995; 368: 331-5.
4. Ouhara K, Komatsuzawa H, Shiba H, Uchida Y, Kawai T, Sayama K, et al. Actinobacillus actinomycetemcomitans outer membrane protein 100 triggers innate immunity and production of beta-defensin and the 18-kilodalton cationic antimicrobial protein through the fibronectin-integrin pathway in human gingival epithelial cells. Infect Immun 2006; 74: 5211-20.
5. Devine DA. Antimicrobial peptides in defence of the oral and respiratory tracts. Mol Immunol 2003; 40: 431-43.
6. Marshall RI. Gingival defensins: linking the innate and adaptive immune responses to dental plaque. Periodontol 2000 2004; 35: 14-20.
7. Lehrer RI. Immunology: Peptide gets in shape for self-defence. Nature 2011; 469: 309-10.
8. Vardar-Sengul S, Demirci T, Sen BH, Erkizan V, Kurulgan E, Baylas H. Human beta defensin-1 and -2 expression in the gingiva of patients with specific periodontal diseases. J Periodontal Res 2007; 42: 429-37.
9. Gomes Pde S, Fernandes MH. Defensins in the oral cavity: distribution and biological role. J Oral Pathol Med 2010; 39: 1-9.
10. Pazgier M, Hoover DM, Yang D, Lu W, Lubkowski J. Human b-defensins. Cell Mol Life Sci 2006; 63: 1294-313.
11. Pazgier M, Li X, Lu W, Lubkowski J. Human defensins: Synthesis and structural properties. Curr Pharm Des 2007; 13: 3096-118.
12. Yang D, Liu ZH, Tewary P, Chen Q, Rosa G, Oppenheim JJ. Defensin participation in innate and adaptive immunity. Curr Pharmaceutic Des 2007; 13: 3131-9.
13. Wimley WC, Selsted ME, White SH. Interactions between human defensins and lipid bilayers: evidence for formation of multimeric pores. Protein Sci 1994; 3: 1362-73.
14. Hancock RE &, Chapple DS Peptide antibiotics. Antimicrob Agents Chemother 1999; 43: 1317-23.
15. Schmidt NW, Mishra A, Lai GH, Davis M, Sanders LK, Tran D et al. Criterion for amino acid composition of defensins and antimicrobial peptides based on geometry of membrane destabilization. J Am Chem Soc 2011; 133: 6720-7.
16. Bowdish DM, Davidson DJ, Hancock RE. Immunomodulatory properties of defensins and cathelicidins. Curr Top Microbiol Immunol 2006; 306: 27-66.
17. Ouhara K, Komatsuzawa H, Yamada S, Shiba H, Fujiwara T, Ohara M, et al. Susceptibilities of periodontopathogenic and cariogenic bacteria to antibacterial peptides, b-defensins and LL-37, produced by human epithelial cells. J Antimicrob Chemother 2005; 55: 888-96.
18. Huang GT, Zhang HB, Kim D, Liu L, Ganz T. A model for antimicrobial gene therapy: demonstration of human betadefensin 2 antimicrobial activities in vivo. Hum Gene Ther 2002; 13: 2017-25.
19. Motzkus D, Schulz-Maronde S, Heitland A, Schulz A, Forssmann WG, Jübner M, et al. The novel b-defensin DEFB123 prevents lipopolysaccharide-mediated effects in vitro and in vivo. FASEB J 2006; 20: 1701-2.
20. Lee SH, Jun HK, Lee HR, Chung CP, Choi BK. Antibacterial and lipopolysaccharide (LPS)-neutralizing activity of human cationic antimicrobial peptides against periodontopathogens. Int J Antimicrob Agents 2010; 35: 138-45.
21. Rosenfeld Y, Papo N, Shai Y. Endotoxin (lipopolysaccharide) neutralization by innate immunity host-defense peptides. Peptide properties and plausible models of action. J Biol Chem 2006; 281: 1636-43.
22. Campos MA, Vargas MA, Regueiro V, Llompart CM, Alberti S, Bengoechea JA. Capsule polysaccharide mediates bacterial resistance to antimicrobial peptides. Infect Immun 2004; 72: 7107-14.
23. Lu Q, Darveau RP, Samaranayake LP, Wang CY, Jin L. Differential modulation of human b-defensins expression in human gingival epithelia by Porphyromonas gingivalis lipopolysaccharide with tetra- and penta-acylated lipid A structures. Innate Immun 2009; 15: 325-35.
24. Otto M. Bacterial evasion of antimicrobial peptides by biofilm formation. Curr Top Microbiol Immunol 2006; 306: 251-8.
25. Maisetta G, Brancatisano FL, Esin S, Campa M, Batoni G. Gingipains produced by Porphyromonas gingivalis ATCC 49417 degrade human-b-defensin 3 and affect peptide's antibacterial activity in vitro. Peptides 2011; 32: 1073-7.
26. Shin JE, Choi Y. Treponema denticola suppresses expression of human beta-defensin-2 in gingival epithelial cells through inhibition of TNF-a production and TLR2 activation. Mol Cells 2010; 29: 407-12.
27. Shin JE, Kim YS, Oh JE, Min BM, Choi Y. Treponema denticola suppresses expression of human b-defensin-3 in gingival epithelial cells through inhibition of the toll-like receptor 2 axis. Infect Immun 2010; 78: 672-9.
28. Joly S, Maze C, McCray PB Jr, Guthmiller JM. Human betadefensins 2 and 3 demonstrate strain-selective activity against oral microorganisms. J Clin Microbiol 2004; 42: 1024-9.
29. Peyret-Lacombe A, Brunel G, Watts M, Charveron M, Duplan H. TLR2 sensing of F. nucleatum and S. sanguis distinctly triggered gingival innate response. Cytokine 2009; 46: 201-10.
30. Ji S, Shin E, Kim YS, Oh JE, Min BM, Choi Y. Toll-like receptor 2 and NALP2 mediate induction of human betadefensins by Fusobacterium nucleatum in gingival epithelial cells. Infect Immun 2009; 77: 1044-52.
31. Krisanaprakornkit S, Kimball JR, Weinberg A, Darveau RP, Bainbridge BW, Dale BA. Inducible expression of human b-defensin 2 by Fusobacterium nucleatum in oral epithelial cells: Multiple signaling pathways and role of commensal bacteria in innate immunity and the epithelial barrier. Infect Immun 2000; 68: 2907-15.
32. Gupta S, Ghosh SK, Scott ME, Bainbridge B, Jiang B, Lamont RJ, et al. Fusobacterium nucleatum-associated beta-defensin inducer (FAD-I): identification, isolation, and functional evaluation. J Biol Chem 2010; 285: 36523-31.
33. Vankeerberghen A, Nuytten H, Dierickx K, Quirynen M, Cassiman JJ, Cuppens H. Differential induction of human beta-defensin expression by periodontal commensals and pathogens in periodontal pocket epithelial cells. J Periodontol 2005; 76: 1293-303.
34. Lamont RJ, Chan A, Belton CM, Izutsu KT, Vasel D, Weinberg A. Porphyromonas gingivalis invasion of gingival epithelial cells. Infect Immun 1995; 63: 3878-85.
35. Amano A. Disruption of epithelial barrier and impairment of cellular function by Porphyromonas gingivalis. Front Biosci 2007; 1: 3965-74.
36. Yang HW, Huang YF, Chan Y, Chou MY. Relationship of Actinobacillus actinomycetemcomitans serotypes to periodontal condition: prevalence and proportions in subgingival plaque. Eur J Oral Sci 2005; 113: 28-33.
37. Ji S, Hyun J, Park E, Lee B-L, Kim K-K, Choi Y. Susceptibility of various oral bacteria to antimicrobial peptides and to phagocytosis by neutrophils. J Periodontal Res 2007; 42: 410-9.
38. Taguchi Y, Imai H. Expression of beta-defensin-2 in human gingival epithelial cells in response to challenge with Porphyromonas gingivalis in vitro. J Periodontal Res 2006; 41: 334-9.
39. Diamond G, Beckloff N, Ryan LK. Host defense peptides in the oral cavity and the lung: similarities and differences. J Dent Res 2008; 87: 915-27.
40. Krisanaprakornkit S, Weinberg A, Perez CN, Dale BA. Expression of the peptide antibiotic human beta-defensin 1 in cultured gingival epithelial cells and gingival tissue. Infect Immun 1998; 66: 4222-8.
41. Schroeder BO, Wu Z, Nuding S, Groscurth S, Marcinowski M, Beisner J, et al. Reduction of disulphide bonds unmasks potent antimicrobial activity of human b-defensin 1. Nature 2011; 469: 419-23.
42. Schroeder BO, Stange EF, Wehkamp J. Waking the wimp: Redox modification activates human beta-defensin 1. Gut Microbes 2011; 2: 262-6.
43. Angelini G, Gardella S, Ardy M, Ciriolo MR, Filomeni G, Di Trapani G, et al. Antigen-presenting dendritic cells provide the reducing extracellular microenvironment required for T lymphocyte activation. Proc Natl Acad Sci U S A 2002; 99: 1491-6.
44. Steeves CH, Potrykus J, Barnett DA, Bearne SL. Oxidative stress response in the opportunistic oral pathogen Fusobacterium nucleatum. Proteomics 2011; 11: 2027-37.
45. Kanda N, Kamata M, Tada Y, Ishikawa T, Sato S, Watanabe S. Human b-defensin-2 enhances IFN-g and IL-10 production and suppresses IL-17 production in T cells. J Leukoc Biol 2011; 89: 935-44.
46. Soruri A, Grigat J, Forssmann U, Riggert J, Zwirner J. Defensins chemoattract macrophages and mast cells but not lymphocytes and dendritic cells: CCR6 is not involved. Eur J Immunol 2007; 37: 2474-86.
47. Yin L, Chino T, Horst OV, Hacker BM, Clark EA, Dale BA, et al. Differential and coordinated expression of defensins and cytokines by gingival epithelial cells and dendritic cells in response to oral bacteria. BMC Immunol 2010; 11: 37.
48. Nishimura M, Abiko Y, Kurashige Y, Takeshima M, Yamazaki M, Kusano K, et al. Effect of defensin peptides on eukaryotic cells: primary epithelial cells, fibroblasts, and squamous cell carcinoma cell lines. J Dermatol Sci 2004; 36: 87-95.
49. Chotjumlong P, Khongkhunthian S, Ongchai S, Reutrakul V, Krisanaprakornkit S. Human b-defensin-3 up-regulates cyclooxygenase-2 expression and prostaglandin E2 synthesis in human gingival fibroblasts. J Periodontal Res 2010; 45: 464-70.
50. Semple F, Webb S, Li HN, Patel HB, Perretti M, Jackson IJ, et al. Human b-defensin 3 has immunosuppressive activity in vitro and in vivo. Eur J Immunol 2010; 40: 1073-8.
51. Häkkinen L, Uitto VJ, Larjava H. Cell biology of gingival wound healing. Periodontol 2000; 24: 127-52.
52. Niyonsaba F, Ushio H, Nakano N, Ng W, Sayama K, Hashimoto K, et al. Antimicrobial peptides human b-defensins stimulate epidermal keratinocyte migration, proliferation, and production of proinflammatory cytokines and chemokines. J Invest Dermatol 2007; 127: 594-604.
53. Otte JM, Werner I, Brand S, Chromik AM, Schmitz F, Kleine M, et al. Human beta defensin 2 promotes intestinal wound healing in vitro. J Cell Biochem 2008; 104: 2286-97.
54. Lu Q, Samaranayake L, Darveau R, Jin L. Expression of b-defensin-3 in gingival epithelia. J Periodontal Res 2005; 40: 474-81.
55. Supp DM, Karpinski AC, Boyce ST. Expression of human b-defensin HBD-1, HBD-2, and HBD-3 in cultured keratinocytes and skin substitutes. Burns 2004; 30: 643-8.
56. Gursoy UK, Pöllänen M, Könönen E, Uitto VJ. A novel organotypic dento-epithelial culture model: Effect of Fusobacterium nucleatum biofilm on b-defensin-2, -3, and LL-37 expression. J Periodontol 2012; 83: 242-7.
57. Lu Q, Jin L, Darveau RP, Samaranayake LP. Expression of human b-defensins-1 and -2 peptides in unresolved chronic periodontitis. J Periodontal Res 2004; 39: 221-7.
58. Bissell J, Joly S, Johnson GK, Organ CC, Dawson D, McCray PB Jr et al. Expression of b-defensins in gingival health and in periodontal disease. J Oral Pathol Med 2004; 33; 278-85.
59. Hosokawa I, Hosokawa Y, Komatsuzawa H, Goncalves RB, Karimbux N, Napimoga MH, et al. Innate immune peptide LL-37 displays distinct expression pattern from beta-defensins in inflamed gingival tissue. Clin Exp Immunol 2006; 146: 218-25.
60. Offenbacher S, Barros SP, Paquette DW, Winston JL, Biesbrock AR, Thomason RG, et al. Gingival transcriptome patterns during induction and resolution of experimental gingivitis in humans. J Periodontol 2009; 80: 1963-82.
61. Dunsche A, Açil Y, Dommisch H, Siebert R, Schröder JM, Jepsen S. The novel human beta-defensin-3 is widely expressed in oral tissues. Eur J Oral Sci 2002; 110: 121-4.
62. Kuula H, Salo T, Pirilä E, Hagström J, Luomanen M, Gutierrez-Fernandez A, et al. Human b-defensin-1 and -2 and matrix metalloproteinase-25 and -26 expression in chronic and aggressive periodontitis and in peri-implantitis. Arch Oral Biol 2008; 53: 175-86.
63. Brancatisano FL, Maisetta G, Barsotti F, Esin S, Miceli M, Gabriele M, et al. Reduced human beta defensin 3 in individuals with periodontal disease. J Dent Res 2011; 90: 241-5.
64. Taggart CC, Greene CM, Smith SG, Levine RL, McCray PB Jr, O'Neill S, et al. Inactivation of human b-defensins 2 and 3 by elastolytic cathepsins. J Immunol 2003; 171: 931-7.
65. Brissette CA, Simonson LG, Lukehart SA. Resistance to human b-defensins is common among oral treponemes. Oral Microbiol Immunol 2004; 19: 403-7.
66. Rivas-Santiago B, Serrano CJ, Enciso-Moreno JA. Susceptibility to infectious diseases based on antimicrobial peptide production. Infect Immun 2009; 77: 4690-5.
67. Jurevic RJ, Bai M, Chadwick RB, White TC, Dale BA. Singlenucleotide polymorphisms (SNPs) in human b-defensin 1: highthroughput SNP assays and association with Candida carriage in type I diabetics and nondiabetic controls. J Clin Microbiol 2003; 41: 90-6.
68. Ozturk A, Famili P, Vieira AR. The antimicrobial peptide DEFB1 is associated with caries. J Dent Res 2010; 89: 631-6.
69. Tiszlavicz Z, Szabolcs A, Takács T, Farkas G, Kovács-Nagy R, Szántai E, et al. Polymorphisms of beta defensins are associated with the risk of severe acute pancreatitis. Pancreatology 2010; 10: 483-90.
70. Wang H, Watanabe H, Ogita M, Ichinose S, Izumi Y. Effect of human b-defensin-3 on the proliferation of fibroblasts on periodontally involved root surfaces. Peptides 2011; 32: 888-94.